Latest filing published 02 Mar 2022 for EXAGEN INC., €27k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Fortunato R. Rocca: trading record in brief
Fortunato R. Rocca (chief executive) discloses dealings in Exagen Inc. to SEC (Form 4). We count 3 filings; the first trade dates from 23 February 2021 and the latest from 1 March 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 2 March 2022 came the latest disclosure, a share grant for €27k in Exagen Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Fortunato R. Rocca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,322 shares@ US$7.12100.0% of flowCommon StockSEC:0001274737-22-000016:0
- 75,000 shares0Common StockSEC:0001274737-22-000008:0
2 of 2 declarations
